Global Anderson Cascade Impactor demand is anticipated to be valued at US$ 5.3 Billion in 2022, forecast to grow at a CAGR of 5.2% to be valued at US$ 8.8 Billion from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | US$ 5 Billion |
| Expected Market Value (2022) | US$ 5.3 Billion |
| Anticipated Forecast Value (2032) | US$ 8.8 Billion |
| Projected Growth Rate (2022 to 2032) | 5.2% CAGR |
The Andersen Cascade Impactor (ACI) is the most commonly used instrument in the Pharmaceutical Sector for testing inhaler products. Westech ACIs are specifically designed to meet the most stringent criteria outlined in the various. Pharmacopoeias for describing the aerosol clouds emitted by inhalers. The Fine Particle Fraction, Fine Particle Dose, Mass Median Aerodynamic Diameter (MMAD), and Geometric Standard Deviation (GSD) can all be calculated by analyzing the drug deposited on the individual stages and the final filter.
The specifications of the Westech 8-stage impactor for use in the testing of MDIs and DPIs are clearly defined in Apparatus D of the EP and Apparatus 1 & 3 of the USP. A general Anderson cascade impactor operates on the principle of particle separation based on size and velocity. The particles are first administered through an open nozzle, where they are collected, and then passed through a series of discs designed to collect solids and various particulate matter. Because the disposition of particles in each of the Anderson Cascade Impactor mesh stages resembles the disposition pattern in various regions of the human lung, the human respiratory tract is a classification similar to the Anderson cascade impactor for inhaling particles. The Anderson Cascade Impactor, which holds eight of these mesh discs, is the most commonly used cascade impactor in the cascade impactor market.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The pharmaceutical industry has a high demand for inhalation product development in order to develop treatments that deliver systematic drugs via the pulmonary route. As asthma and chronic obstructive pulmonary diseases (COPD) become more common, and there is a growing reputation for Anderson cascade impactors, the industry is responding by investing heavily in both formulation and device research in the Anderson cascade impactor market, and this becomes the market's best driving effect.
While Anderson cascade impactor have many advantages over all other methods, they are bulky and not very portable, making them difficult to use in an industrial setting, and the disc membrane provided by TOEM does not provide any size information. Such factors are discouraging industrials from effectively suing Anderson cascade impactor, ultimately harming the cascade impactor market as a whole.
Principal Consultant
The Anderson cascade impactor market is extensive in European regions such as Switzerland, France, and the United Kingdom, and it is expected to grow by 25% because Europe is known for its innovation and many products in the R&D stages.
According to Future Market Insights, North America is a major Anderson cascade impactor demand and supply chain influencer due to its influences in the pharmaceutical market, both in consumption and development, with medical spending expected to increase by 5% per year from 2022 to 2032, reaching approximately $7 trillion.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key participants present in the global Anderson Cascade Impactor market include MSP Corporation, Thermo Fisher Scientific, Tisch Environmental Incorporated, Apex Chromatography Private Limited, BGI Incorporated, Mesa Laboratories Incorporated, SKC Incorporated and Copley Scientific among others.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.2% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Mesh Disc Stage Units, Particle Bounce, Sample Collection Filters, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; Asia Pacific; Japan; Middle East and Africa |
| Key Countries Profiled | USA, Canada, Brazil, Argentina, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
| Key Companies Profiled | MSP Corporation; Thermo Fisher Scientific; Tisch Environmental Incorporated; Apex Chromatography Private Limited; BGI Incorporated; Mesa Laboratories Incorporated; SKC Incorporated; Copley Scientific |
| Customization | Available Upon Request |
FMI projects the global Anderson Cascade Impactor market to expand at a 5.2% value CAGR by 2032
Asia Pacific is expected to be the most opportunistic Anderson Cascade Impactor market, expanding at a 5% CAGR
MSP Corporation, Thermo Fisher Scientific, Tisch Environmental Incorporated, Apex Chromatography Private Limited, BGI Incorporated, Mesa Laboratories Incorporated, SKC Incorporated and Copley Scientific are some prominent Anderson Cascade Impactor manufacturers.
Explore Testing Equipment Insights
View Reports
Anderson Cascade Impactor Market
